Hospital or health organisation · founded 1876
The University of Texas MD Anderson Cancer Center
Houston, United States · mdanderson.org
- Citations, last 5 years
- 470.2k
- Works, last 5 years
- 44.3k
- h-index
- 1,800
- Scientists listed
- 5 302
- Grants since 2016
- 2 323
Grants received
2023 · grant · CPRIT Scholar
Recruitment of First-Time, Tenure-Track Faculty Members
Kenneth Hu · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2028 · research · R01
Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer
Dihua Yu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · research · R21
Boosting anti-tumor immunity in the omentum for metastasis prevention
Honami Naora · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2024 · research · R01
Revisiting Antiangiogenic Therapy to Target Hormone-Sensitive Prostate Cancer Metabolism
Daniel Edward Frigo · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · award
Discovery of metastasis driver genes
Li Ma · The University of Texas MD Anderson Cancer Center · funded by American Cancer Society
2023 · grant · Academic Research
Enhancing Immune Responses in Pancreatic Cancer by Stromal Inhibition of HIF2
Michael Spiotto · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023 · grant · Academic Research
Integrative modeling of spatially resolved multi-omics data to identify bladder cancer mucosal field effects
Peng Wei · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2028 · research · R37
Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy
Simon Eschweiler · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · grant · Academic Research
Targeting the Mlc1-GlialCAM Protein Complex in Invasive Glioma Cells
Joseph Mccarty · The University of Texas MD Anderson Cancer Center · funded by Cancer Prevention and Research Institute of Texas
2023–2028 · research · R01
Targeting Non-Canonical STING Signaling to Treat SPOP Mutant Castration-Resistant Prostate Cancer
Timothy Charles Thompson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023 · research · PCF Challenge Award
A Pilot Presurgical Trial of REGN5678 (Anti-PSMAxCD28) In Patients with High-Risk, Localized Prostate Cancer Followed by Radical Prostatectomy
Padmanee Sharma · The University of Texas MD Anderson Cancer Center · funded by Prostate Cancer Foundation
2023 · research
Maximizing the effectiveness of breast cancer radiation treatments while avoiding an increased risk of heart disease
Wendy Woodward · The University of Texas MD Anderson Cancer Center · funded by Breast Cancer Research Foundation
2023 · research · AACR-Novocure Career Development Awards for TTFields Research
Tumor treating field modulation of metastatic bone tumor microenvironment
Christopher A. Alvarez-Breckenridge · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2023 · research · AACR Career Development Award in Lung Cancer Research
T cell receptor engineering for the treatment of lung cancer
Alexandre Reuben · The University of Texas MD Anderson Cancer Center · funded by American Association for Cancer Research
2023 · career development · Young Investigator Award
WRN inhibition in microsatellite instability high colorectal cancer
Deepak Bhamidipati · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Young Investigator Award
Delineating the impact of clonal hematopoiesis in patients with non-small cell lung cancer treated with immune checkpoint inhibitors
Samuel Urrutia · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Career Development Award
Identifying Predictive Biomarkers for Early Detection and Intervention to Improve Outcomes in Severe Cardiac and Neuromuscular Immune-Related Adverse Events (irAEs)
Bilal Siddiqui · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Career Development Award
CD70 Chimeric Antigen Receptor Natural Killer Cells in the Treatment of Relapsed/Refractory Multiple Myeloma
Paul Lin · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Young Investigator Award
Adaptive mutability in colorectal cancers treated with epidermal growth factor receptor inhibition
Madhulika Eluri · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Young Investigator Award
Targeting Small Cell Lung Cancer Through MAGEA4 T-Cell Receptor (TCR) Therapy
Kyle Concannon · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Young Investigator Award
Radiogenomic Predictor for Radioresistance and Pathologic Response in Esophageal Cancer Patients who Undergo Trimodality Therapy
Vincent Bernard Pagan · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Young Investigator Award
Synergizing preconditioning radiotherapy with CAR-NK cell therapy for head and neck cancer
Gohar Manzar · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Young Investigator Award
T-cell Exhaustion and the Systemic Immune Response to Metastasis-Directed Radiotherapy in Metastatic Renal Cell Carcinoma
Alexander Sherry · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Young Investigator Award
Recombinant IL-15, NKTR-255, to inhibit T-cell exhaustion and improve metabolic fitness of CAR T cells
Irtiza Sheikh · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Young Investigator Award
Determining the Clonal Hierarchy and Immunophenotype of Acute Myeloid Leukemia with WT1 Mutation
Himachandana Atluri · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Young Investigator Award
Epigenetic Optimization of CAR T-cells for Durable Memory
Casey Bermack · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023 · career development · Young Investigator Award
Clinical Correlations of ctDNA in Locally Advanced Rectal Cancer
Andrew Pellatt · The University of Texas MD Anderson Cancer Center · funded by Conquer Cancer Foundation
2023–2027 · research · R01
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
Albert Koong · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2026 · research · R21
Targeting MDM4 in Rare Refractory Ovarian Cancer Sub-Types
Zahid H Siddik · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · program · P50
The University of Texas MD Anderson Cancer Center SPORE in Ovarian Cancer
Robert C Bast · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R50
A radiation oncology clinician scientist devoted to building an inclusive clinical research program in an integrated academic satellite network in service to the National Cancer Institute
Stephen G Chun · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · cooperative agreement · U01
Identifying and targeting collateral lethal vulnerabilities in cancers
Ronald Anthony Depinho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Targeting Non-Canonical STING Signaling to Treat SPOP Mutant Castration-Resistant Prostate Cancer
Timothy Charles Thompson · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Integrating Epidemiologic and Genomic Data to Elucidate the Genetic Overlap Between Congenital Anomalies and Pediatric Cancer
Chad Daniel Huff · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Novel Biomarkers Predicting Blood Clots in Ovarian Cancer
Vahid Afshar-Kharghan · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Alpha particles combined with ATR inhibition to activate the immune system: mechanisms and pre-clinical translation
Gabriel Oliveira Sawakuchi · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2027 · contract · N01
Targeting the A2B Adenosine Receptor for Immunoprevention of Pancreatic Cancer
Xiangwei Wu · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
The Impact of Biologic Aging on Immunity-Related Cervical Cancer Outcome Disparities Among Women Living with HIV in Zambia
Anna Coghill · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2028 · research · R01
Mechanism-rooted therapeutic strategies for immune-related toxicities induced by checkpoint inhibitors
Roza Insafetdinovna Nurieva · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
2023–2025 · research · R34
Randomized controlled trial to test feasibility of a culturally adapted meditation-based support intervention for Black patients dealing with advanced cancer
Dalnim Cho · The University of Texas MD Anderson Cancer Center · funded by National Institutes of Health
